Thiogenesis Therapeutics Ownership
Who are the major shareholders and have insiders been buying or selling?
Recent Insider Transactions
Date | Value | Name | Entity | Role | Shares | Max Price |
---|---|---|---|---|---|---|
15 Dec 23 | BuyCA$37,500 | Brook G. Riggins | Individual | 50,000 | CA$0.75 | |
24 Jul 23 | SellCA$84,717 | Vincent Stanton | Individual | 124,000 | CA$0.78 |
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Ownership Breakdown
Owner Type | Number of Shares | Ownership Percentage |
---|---|---|
Individual Insiders | 10,138,869 | 22.3% |
General Public | 35,356,706 | 77.7% |
Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 17.1%.
Top Shareholders
Ownership | Name | Shares | Current Value | Change % | Portfolio % | |
---|---|---|---|---|---|---|
6,737,869 | CA$4.9m | 0% | no data | |||
1,476,000 | CA$1.1m | 0% | no data | |||
1,050,000 | CA$756.0k | 5% | no data | |||
875,000 | CA$630.0k | 0% | no data |